Cite

HARVARD Citation

    Huseni, M. et al. (n.d.). Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record